Aquestive Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AQST and other ETFs, options, and stocks.About AQST
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz.
AQST Key Statistics
Stock Snapshot
The current Aquestive Therapeutics(AQST) stock price is $4.15, with a market capitalization of 519.73M. The stock trades at a price-to-earnings (P/E) ratio of -6.21.
As of 2026-03-05, Aquestive Therapeutics(AQST) stock has fluctuated between $4.14 and $4.49. The current price stands at $4.15, placing the stock +0.4% above today's low and -7.6% off the high.
Aquestive Therapeutics(AQST) shares are trading with a volume of 4.86M, against a daily average of 2.28M.
During the past year, Aquestive Therapeutics(AQST) stock moved between $2.12 at its lowest and $7.55 at its peak.
During the past year, Aquestive Therapeutics(AQST) stock moved between $2.12 at its lowest and $7.55 at its peak.
AQST News
The latest announcement is out from Aquestive Therapeutics ( (AQST) ). On March 3, 2026, Aquestive Therapeutics amended its existing revenue-sharing Purchase a...
Reports Q4 revenue $13.02M, consensus $13.28M. “We are well-positioned in 2026 to advance Anaphylm, the first and only oral epinephrine rescue medication, towar...
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.